Modes of p53 regulation.

Kruse, Jan-Philipp, Gu, Wei·2009·Cell

Cited by (1,000)

Items 101–200 of 1,000

  1. p53 regulation by ubiquitin
    Brooks, Christopher L., Gu, Wei · 2011 · FEBS Letters
  2. 53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms
    Raquel Cuella-Martin, Catarina Oliveira, Helen E. Lockstone, Suzanne Snellenberg, Natalia Grolmusova, J. Ross Chapman · 2016 · Molecular Cell
  3. Small Changes, Big Impact
    Dagmar E. Ehrnhoefer, Liza M. Sutton, Michael R. Hayden · 2011 · The Neuroscientist
  4. ATM‐mediated phosphorylation of SOG1 is essential for the DNA damage response in Arabidopsis
    Kaoru Yoshiyama, Junya Kobayashi, Nobuo Ogita, Minako Ueda, Seisuke Kimura, Hisaji Maki, Masaaki Umeda · 2013 · EMBO Reports
  5. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells
    Wade M. Borcherds, François‐Xavier Theillet, Andrea Katzer, Ana Finzel, Katie M. Mishall, Anne Terese Powell, Hongwei Wu, Wanda Manieri, Christoph Dieterich, Philipp Selenko et al. · 2014 · Nature Chemical Biology
  6. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11
    Masato Sasaki, Kohichi Kawahara, Miki Nishio, Koshi Mimori, Ryunosuke Kogo, Koichi Hamada, Bunsho Itoh, Jia Wang, Yukako Komatsu, Yong Ryoul Yang et al. · 2011 · Nature Medicine
  7. Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and P53 signaling
    Hongbing Fu, Changming Wang, Dejun Yang, Ziran Wei, Jiapeng Xu, Zunqi Hu, Yu Xin Zhang, Weimin Wang, Ronglin Yan, Qingping Cai · 2017 · Journal of Cellular Physiology
  8. Essential role for the interaction between hnRNP H/F and a G quadruplex in maintaining p53 pre-mRNA 3′-end processing and function during DNA damage
    Adrien Decorsière, Anne Cayrel, Stéphan Vagner, Stefania Millevoi · 2011 · Genes & Development
  9. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis
    Anna Stengel, Susanne Schnittger, Sandra Weißmann, Sabrina Kuznia, Wolfgang Kern, Alexander Kohlmann, Torsten Haferlach, Claudia Haferlach · 2014 · Blood
  10. Ribosomal protein S14 unties the MDM2–p53 loop upon ribosomal stress
    Xiang Yu Zhou, Qin Hao, Jingling Liao, Q Zhang, Hua Lu · 2012 · Oncogene
  11. Ribosomal Proteins RPL37, RPS15 and RPS20 Regulate the Mdm2-p53-MdmX Network
    Lilyn Daftuar, Yan Yu Zhu, Xavier Jacq, Carol L. Prives · 2013 · PLoS ONE
  12. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice
    Takahiro Kodama, Tetsuo Takehara, Hayato Hikita, Satoshi Shimizu, Minoru Shigekawa, Hinako Tsunematsu, Wei Shan Li, Takuya Miyagi, Atsushi Hosui, Tomohide Tatsumi et al. · 2011 · Journal of Clinical Investigation
  13. Push back to respond better: regulatory inhibition of the DNA double-strand break response
    Stephanie Panier, Daniel Durocher · 2013 · Nature Reviews Molecular Cell Biology
  14. The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
    Ines Oršolić, Deana Jurada, Nick Pullen, Moshe Oren, Aristides G. Eliopoulos, Siniša Volarević · 2015 · Seminars in Cancer Biology
  15. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest
    Navin Sarin, Florian Engel, Ganna V. Kalayda, Mareike Mannewitz, Jindrich Jr. Cinatl, Florian Rothweiler, Martin Michaelis, Hisham Saafan, Christoph Alexander Ritter, Ulrich Jaehde et al. · 2017 · PLoS ONE
  16. When ribosomes go bad: diseases of ribosome biogenesis
    Emily F. Freed, Franziska Bleichert, Laura M. Dutca, Susan J. Baserga · 2010 · Molecular BioSystems
  17. Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
    Ido Goldstein, Virginie Marcel, Magali Olivier, Moshe Oren, Varda Rotter, Pierre L. Hainaut · 2010 · Cancer Gene Therapy
  18. Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity
    Latil, Mathilde, Rocheteau, Pierre, Châtre, Laurent, Sanulli, Serena, Mémet, Sylvie, Ricchetti, Miria, Tajbakhsh, Shahragim, Chrétien, Fabrice · 2012 · Nature Communications
  19. Identifying the target genes of SUPPRESSOR OF GAMMA RESPONSE 1, a master transcription factor controlling DNA damage response in Arabidopsis
    Nobuo Ogita, Yoko Okushima, Mutsutomo Tokizawa, Yoshiharu Y. Yamamoto, Maho Tanaka, Motoaki Seki, Yuko Makita, Minami Matsui, Kaoru Yoshiyama, Tomoaki Sakamoto et al. · 2018 · The Plant Journal
  20. mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53
    Jung, Seung Hee, Hwang, Hyun Jung, Kang, Donghee, Park, Hyun A., Lee, Hyung Chul, Jeong, Daecheol, Lee, Keunwook, Park, Heon Joo, Ko, Young-Gyu, Lee, Jae-Seon · 2019 · Oncogene
  21. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses
    Chen, Delin, Shan, Jing, Zhu, Wei-Guo, Qin, Jun, Gu, Wei · 2010 · Nature
  22. SET1 and p300 Act Synergistically, through Coupled Histone Modifications, in Transcriptional Activation by p53
    Zhanyun Tang, Wei‐Yi Chen, Miho Shimada, Uyen T. T. Nguyen, Jaehoon Kim, Xiao‐Jian Sun, Toru Sengoku, Robert K. McGinty, Joseph Fernandez, Tom W. Muir et al. · 2013 · Cell
  23. Perturbation of Ribosome Biogenesis Drives Cells into Senescence through 5S RNP-Mediated p53 Activation
    Kazuho Nishimura, Takuya Kumazawa, Takao Kuroda, Naohiro Katagiri, Mai Tsuchiya, Natsuka Goto, Ryohei Furumai, Akiko Murayama, Junn Yanagisawa, Keiji Kimura · 2015 · Cell Reports
  24. Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity
    Yuji Wang, Pingxin Li, Shu Wang, Jing Hu, Xiangyun Amy Chen, Jianhui Wu, Megan Fisher, Kira Oshaben, Ying Gu, Ying Gu et al. · 2012 · Journal of Biological Chemistry
  25. Sirt3 protects in vitro–fertilized mouse preimplantation embryos against oxidative stress–induced p53-mediated developmental arrest
    Yumiko Kawamura, Yasunobu Uchijima, Nanao Horike, Kazuo Tonami, Koichi Nishiyama, Tomokazu Amano, Tomoichiro Asano, Yukiko Kurihara, Hiroki Kurihara · 2010 · Journal of Clinical Investigation
  26. p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways
    Mikael S. Lindström, Jiří Bártek, Apolinar Maya‐Mendoza · 2022 · Cell Death and Differentiation
  27. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
    Slađana Bursać, Maja Cokarić Brdovčak, Giulio Donati, Siniša Volarević · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  28. Current developments of targeting the p53 signaling pathway for cancer treatment
    Jing Li Huang · 2020 · Pharmacology & Therapeutics
  29. Caspase-2-Mediated Cleavage of Mdm2 Creates a p53-Induced Positive Feedback Loop
    Trudy G. Oliver, Etienne Meylan, Gregory P. Chang, Wen Xue, James R. Burke, Timothy J. Humpton, Diana Hubbard, Arjun J. Bhutkar, Tyler Jacks · 2011 · Molecular Cell
  30. USP4 inhibits p53 through deubiquitinating and stabilizing ARF‐BP1
    Xinna Zhang, Franklin G. Berger, Jianhua Yang, Xiongbin Lu · 2011 · The EMBO Journal
  31. Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics
    Ainsley Mike Antao, Apoorvi Tyagi, Kye-Seong Kim, Suresh Ramakrishna · 2020 · Cancers
  32. p53 β-hydroxybutyrylation attenuates p53 activity
    Kun Liu, Fangzhou Li, Qianqian Sun, Ning Lin, Haichao Han, Kaiqiang You, Feng Tian, Zebin Mao, Tingting Li, Tanjun Tong et al. · 2019 · Cell Death and Disease
  33. ATM-Dependent Downregulation of USP7/HAUSP by PPM1G Activates p53 Response to DNA Damage
    Svetlana V. Khoronenkova, Irina I. Dianova, Nicola Ternette, Benedikt Mathias Kessler, Jason Luke Parsons, Grigory L. Dianov · 2012 · Molecular Cell
  34. The importance of p53 pathway genetics in inherited and somatic cancer genomes
    Giovanni Stracquadanio, Xuting Wang, Marsha D. Wallace, Anna M. Grawenda, Ping Zhang, Juliet Hewitt, Jorge Zerón-Medina-Cuairán, Francesc Castro-Giner, Ian P.M. Tomlinson, Colin R. Goding et al. · 2016 · Nature reviews. Cancer
  35. JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
    Feng Wang, Lin He, Peiwei Huangyang, Jing Liang, Wenzhe Si, Ruorong Yan, Xiao Han, Shumeng Liu, Bin Gui, Wanjin Li et al. · 2014 · PLoS Biology
  36. A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells
    Kyoung Hwa Lee, Mangmang Li, Aleksandra M. Michalowski, Xinyue Zhang, Hongling Liao, Lingyi Chen, Yang Xu, Xiaolin Wu, Jing Li Huang · 2009 · Proceedings of the National Academy of Sciences
  37. Role of the lncRNA-p53 regulatory network in cancer
    A. Zhang, M. Xu, Yin‐Yuan Mo · 2014 · Journal of Molecular Cell Biology
  38. Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D2concept
    Vladimir Nikolaevich Uversky · 2010 · Expert Review of Proteomics
  39. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes
    Azra Raza, Naomi Galili · 2012 · Nature reviews. Cancer
  40. An overview of transcriptional regulation in response to toxicological insult
    Paul Jennings, Alice Limonciel, Luca Felice, Martin Oliver Leonard · 2012 · Archives of Toxicology
  41. Massively regulated genes: the example of TP53
    Monica C. Hollstein, Pierre L. Hainaut · 2009 · The Journal of Pathology
  42. p53 and stem cells: new developments and new concerns
    Tongbiao Zhao, Yang Xu · 2010 · Trends in Cell Biology
  43. Regulation of p53: a collaboration between Mdm2 and MdmX
    Pei, Dongsheng, Zhang, Yanping, Zheng, Junnian · 2012 · Oncotarget
  44. Eukaryotic transcription factors: paradigms of protein intrinsic disorder
    Lasse Staby, Charlotte O’Shea, Martin Willemoës, Frederik Friis Theisen, Birthe Brandt Kragelund, Karen Skriver · 2017 · Biochemical Journal
  45. The regulatory roles of p53 in cardiovascular health and disease
    Hongbo Men, He Cai, Quanli Cheng, Wenqian Zhou, Xiang Wang, Shan Huang, Yang Zheng, Lu Cai · 2020 · Cellular and Molecular Life Sciences
  46. The role of ribosomal proteins in the regulation of cell proliferation, tumorigenesis, and genomic integrity
    Xilong Xu, Xiufang Xiong, Yi Sun · 2016 · Science China Life Sciences
  47. S6K1 is a multifaceted regulator of Mdm2 that connects nutrient status and DNA damage response
    Keng Po Lai, Wai Fook Leong, Jenny Fung Ling Chau, Deyong Jia, Li Zeng, Huijuan Liu, Lin He, Aijun Hao, Hongbing Zhang, David W. Meek et al. · 2010 · The EMBO Journal
  48. Inositol Pyrophosphates Mediate the DNA-PK/ATM-p53 Cell Death Pathway by Regulating CK2 Phosphorylation of Tti1/Tel2
    Feng Rao, Jiyoung Cha, Jing Xu, Risheng Xu, Matthew Scott Vandiver, Richa Tyagi, Robert A. Tokhunts, Michael A. Koldobskiy, Chenglai Fu, Roxanne K. Barrow et al. · 2014 · Molecular Cell
  49. RP–MDM2–p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
    Yong Liu, Chad Deisenroth, Yanping Zhang · 2016 · Trends in cancer
  50. The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells
    Tetsuya Gotoh, Marian Vila-Caballer, Carlo S. Santos, Jingjing Liu, Jianhua Yang, Carla V. Finkielstein · 2014 · Molecular Biology of the Cell
  51. New insights into p53 activation
    Christopher L. Brooks, Wei Jun Gu · 2010 · Cell Research
  52. From structure to dynamics: Frequency tuning in the p53–Mdm2 network
    Wassim Abou-Jaoudé, Djomangan Adama Ouattara, Marcelle Kaufman · 2009 · Journal of Theoretical Biology
  53. Translational repression of p53 by RNPC1, a p53 target overexpressed in lymphomas
    Jin Zhang, Seong-Jun Cho, Limin Shu, Wensheng Yan, Teri A. Guerrero, Michael Sean Kent, Katherine A. Skorupski, Hong-Wu Chen, Xinbin Chen · 2011 · Genes & Development
  54. Akt: a key transducer in cancer
    Pei‐Jane Tsai, Yi‐Hsin Lai, Rajesh Manne, Yau-Sheng Tsai, Dos D. Sarbassov, Hui‐Kuan Lin · 2022 · Journal of Biomedical Science
  55. Structures of closed and open conformations of dimeric human ATM
    Domagoj Baretić, Hannah Pollard, David I. Fisher, Christopher M. Johnson, Balaji Santhanam, C. Truman, Tomáš Kouba, Alan Roy Fersht, Christopher Phillips, Roger L. Williams · 2017 · Science Advances
  56. Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
    Lingfeng He, Hong Zhu, Shiying Zhou, Ting Wu, Huan Wu, Huan Yang, Huiwen Mao, Chandrasekhar Kathera, Avilala Janardhan, Ashlin M. Edick et al. · 2018 · Experimental & Molecular Medicine
  57. Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
    He, Yonghan, Khan, Sajid, Huo, Zhiguang, Lv, Dongwen, Zhang, Xuan, Liu, Xingui, Yuan, Yaxia, Hromas, Robert, Xu, Mingjiang, Zheng, Guangrong et al. · 2020 · Journal of Hematology & Oncology
  58. Runx3 Inactivation Is a Crucial Early Event in the Development of Lung Adenocarcinoma
    You‐Soub Lee, Jung-Won Lee, Juwon Jang, Xin‐Zi Chi, Jang‐Hyun Kim, Yinghui Li, Minkyu Kim, Da-Mi Kim, Byeung-Sub Choi, Eung‐Gook Kim et al. · 2013 · Cancer Cell
  59. Dissenting degradation: Deubiquitinases in cell cycle and cancer
    Thomas Bonacci, Michael J. Emanuele · 2020 · Seminars in Cancer Biology
  60. PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage
    Anton Vichalkovski, Ekaterina Gresko, D Hess, David F. Restuccia, Brian A. Hemmings · 2010 · Oncogene
  61. SIRT1 Regulates Autoacetylation and Histone Acetyltransferase Activity of TIP60
    Jiadong Wang, Junjie Chen · 2010 · Journal of Biological Chemistry
  62. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention
    Abhik Saha, Rajeev Kaul, Masanao Murakami, Erle S. Robertson · 2010 · Cancer Biology & Therapy
  63. Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53
    Céline Charvet, Manuela Wissler, Prisca Brauns‐Schubert, Shang-Jui Wang, Yi Tang, Florian Christoph Sigloch, Hestia S. Mellert, Martin Brandenburg, Silke E. Lindner, Bernhard Breit et al. · 2011 · Molecular Cell
  64. The ribosomal protein S26 regulates p53 activity in response to DNA damage
    Dan Cui, L Li, Huiqiang Lou, Hong‐Wei Sun, S.H.O. Ngai, Genze Shao, Jun Tang · 2013 · Oncogene
  65. Targeted Deletion of p53 in the Proximal Tubule Prevents Ischemic Renal Injury
    Ying Yuan, Jinu Kim, Sherry N. Westphal, Kelly E. Long, Babu J. Padanilam · 2014 · Journal of the American Society of Nephrology
  66. The complex landscape of pancreatic cancer metabolism
    C. M. Sousa, Alec C. Kimmelman · 2014 · Carcinogenesis
  67. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells
    Seung Woo Lee, Hyun-Kyung Kim, Na Hyeon Lee, Hee-Yeon Yi, Hong-Sug Kim, Sung Hee Hong, Yong-Kil Hong, Young Ae Joe · 2015 · Cancer Letters
  68. Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
    Razmik Mirzayans, Bonnie Andrais, April Scott, Ying Wang, David L. Murray · 2013 · International Journal of Molecular Sciences
  69. Ubiquitin becomes ubiquitous in cancer
    Dingding Shi, Steven R. Grossman · 2010 · Cancer Biology & Therapy
  70. p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization
    Daniel K. Fox, Scott Matthew Ebert, Kale S. Bongers, Michael C. Dyle, Steven A. Bullard, Jason M. Dierdorff, Steven D. Kunkel, Christopher M. Adams · 2014 · American Journal of Physiology-Endocrinology and Metabolism
  71. From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer
    Sarah S Knox · 2010 · Cancer Cell International
  72. Dietary downregulation of mutant p53 levels via glucose restriction
    Olga Catalina Rodriguez, Sujatra Choudhury, Vamsi Krishna Kolukula, Eveline E. Vietsch, Jason Catania, Anju Preet, Katherine Reynoso, Jill Bargonetti, Anton Wellstein, Chris Albanese et al. · 2012 · Cell Cycle
  73. Inhibition of USP7 activity selectively eliminates senescent cells in part via restoration of p53 activity
    Yonghan He, Wen Li, Dongwen Lv, Xin Zhang, Xuan Zhang, Yuma T. Ortiz, Vivekananda Budamagunta, Judith Campisi, Guangrong Zheng, Daohong Zhou · 2020 · Aging Cell
  74. MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
    Xinjiang Wang, Junru Wang, Xuejun Jiang · 2011 · Journal of Biological Chemistry
  75. p53 ancestry: gazing through an evolutionary lens
    Lu, Wan-Jin, Amatruda, James F., Abrams, John M. · 2009 · Nature reviews. Cancer
  76. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
    Fujun Li, Lixia Miao, Teng Xue, Hao Qin, Santanu Mondal, Paul R. Thompson, Scott Alexander Coonrod, Xiaoqiu Liu, Xuesen Zhang · 2019 · Journal of Experimental & Clinical Cancer Research
  77. Puma is required for p53-induced depletion of adult stem cells
    Dongping Liu, Linda Ye Ou, Gregory Dane Clemenson, Connie Chao, Marshall Eli Lutske, Gerard P. Zambetti, Fred H. Gage, Yang Xu · 2010 · Nature Cell Biology
  78. Regulators of Oncogenic Mutant TP53 Gain of Function
    Satomi Yamamoto, Tomoo Iwakuma · 2018 · Cancers
  79. The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
    Anna Mandinova, Sam W. Lee · 2011 · Science Translational Medicine
  80. Human single-stranded DNA binding proteins are essential for maintaining genomic stability
    Nicholas William Ashton, Emma Bolderson, Liza Cubeddu, Kenneth John O'Byrne, Derek J. Richard · 2013 · BMC Molecular Biology
  81. Regulation of cell differentiation by the DNA damage response
    Mara H. Sherman, Craig H. Bassing, Michael A. Teitell · 2011 · Trends in Cell Biology
  82. Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21
    Naoto Tsuchiya, Masashi Izumiya, Hiroko Ogata‐Kawata, Koji Okamoto, Yuko Fujiwara, Makiko Nakai, Atsushi Okabe, Aaron J. Schetter, Elise D. Bowman, Yutaka Midorikawa et al. · 2011 · Cancer Research
  83. Regulatory non-coding RNA: new instruments in the orchestration of cell death
    Ye Su, Haijiang Wu, Alexander Pavlosky, Linglin Zou, Xinna Deng, Zhu‐Xu Zhang, Anthony M. Jevnikar · 2016 · Cell Death and Disease
  84. Targeting intrinsically disordered proteins involved in cancer
    Patricia Santofimia‐Castaño, Bruno Rizzuti, Yi Xia, Olga Abián, Ling Peng, Adrián Velázquez‐Campoy, José L. Neira, Juan Iovanna · 2019 · Cellular and Molecular Life Sciences
  85. p53-mediated apoptosis requires inositol hexakisphosphate kinase-2
    Michael A. Koldobskiy, Anutosh Chakraborty, J. Kent Werner, Adele M. Snowman, Krishna R. Juluri, Matthew Scott Vandiver, Seyun Kim, Shira Heletz, Solomon H. Snyder · 2010 · Proceedings of the National Academy of Sciences
  86. Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53
    S. Rajagopalan, Fang Lue Huang, Alan Roy Fersht · 2010 · Nucleic Acids Research
  87. NRF2 and p53: Januses in cancer?
    Barak Rotblat, Gerry Melino, Richard A. Knight · 2012 · Oncotarget
  88. Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation
    Saptarsi M. Haldar, Yuan Lu, Darwin Jeyaraj, Daiji Kawanami, Yingjie Cui, Sam J. Eapen, Caili Hao, Yan Li, Yong‐Qiu Doughman, Michiko Watanabe et al. · 2010 · Science Translational Medicine
  89. A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53
    Qi Zhang, Shelya X. Zeng, Yu Zhang, Yi-Wei Zhang, Derong Ding, Qi-Zhuang Ye, Samy O. Meroueh, Hua Lu · 2012 · EMBO Molecular Medicine
  90. The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
    Tae‐Dong Kim, Sook Shin, William L. Berry, Sangphil Oh, Ralf Janknecht · 2011 · Journal of Cellular Biochemistry
  91. A novel 3’tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer
    Huai-Ping Cui, Han-Wen Li, Hao Wu, Fengying Du, Xiaozhou Xie, Shu-Jie Zeng, Zi-Hao Zhang, K. Dong, L. Shang, C. Jing et al. · 2022 · Cell Death and Disease
  92. Life or Death after a Break: What Determines the Choice?
    Lenno Krenning, Jeroen van den Berg, René H. Medema · 2019 · Molecular Cell
  93. MST1 mediates neuronal loss and cognitive deficits: A novel therapeutic target for Alzheimer’s disease
    Wang, Hui, Shang, Yingchun, Wang, Enlin, Xu, Xinxin, Zhang, Qiyue, Qian, Chenxi, Yang, Zhuo, Wu, Shian, Zhang, Tao · 2022 · Progress in Neurobiology
  94. An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells
    Mangmang Li, Hongfeng Gou, Brajendra K. Tripathi, Jing Li Huang, Shunlin Jiang, Wendy Dubois, Tim Waybright, Ming Lei, Jianxin Shi, Ming Zhou et al. · 2015 · Cell stem cell
  95. A Nuclear Phosphoinositide Kinase Complex Regulates P53
    Choi, Suyong, Chen, Mo, Cryns, Vincent L., Anderson, Richard A. · 2019 · Nature Cell Biology
  96. The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
    Danrui Cui, Ruirui Qu, Dian Liu, Xiufang Xiong, Tingbo Liang, Yongchao Zhao · 2021 · Frontiers in Cell and Developmental Biology
  97. DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control
    Xi Chen, Jia Chen, Siting Gan, Huaji Guan, Yuan Zhou, Qi Ouyang, Jue Shi · 2013 · BMC Biology
  98. AMP-Activated Protein Kinase Induces p53 by Phosphorylating MDMX and Inhibiting Its Activity
    Guifen He, Yi-Wei Zhang, Jun‐Ho Lee, Shelya X. Zeng, Yunyuan V. Wang, Zhijun Luo, Xiaocheng Charlie Dong, Benoı̂t Viollet, Geoffrey M. Wahl, Hua Lu · 2013 · Molecular and Cellular Biology
  99. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death
    Venkatesan, Balachandar, Prabhu, Sumanth D., Venkatachalam, Kaliyamurthi, Mummidi, Srinivas, Valente, Anthony J., Clark, Robert A., Delafontaine, Patrice, Chandrasekar, Bysani · 2010 · Cellular Signalling
  100. Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer
    Takayama, Ken-ichi, Suzuki, Takashi, Fujimura, Tetsuya, Takahashi, Satoru, Inoue, Satoshi · 2018 · Molecular Cancer Research